Lamotrin-Mepha 50 mg, Tabletten - 60 Tablette(n) Swissmedic Key 57137014 Registration Holder Mepha Pharma AG Name Lamotrin-Mepha 50 mg, Tabletten Date of registration 14.07.2005 Original/Generic Generic Introduction of Sequence 14.07.2005 ATC-Classification Lamotrigine (N03AX09) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.07.10. Show package size 60 Tablette(n) Index Therapeuticus (Swissmedic) 01.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 16.34 Limitation No Deductible 10 % Consumer price 34.05 Feedback FB Daily cost GTIN 7680571370141 Medication Code Synthetika Pharmacode 3013569 Disponibility
Composition lamotriginum 50 mg, calcii carbonas, sorbitolum 5.835 mg, cellulosum microcristallinum silicificatum, crospovidonum, maydis amylum, talcum, aromatica, saccharinum natricum corresp. natrium 0.412 mg, natrii stearylis fumaras, silica colloidalis anhydrica pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Lamotrigine 50 mg
BAG: Active Agent Dose Lamotrigine 50 mg
Inactive agents Dose Aromatica Calcium Carbonate Cellulosum Microcristallinum Silicificatum Crospovidonum Maydis Amylum Natrii Stearylis Fumaras Saccharinum Natricum Silica Colloidalis Anhydrica pro Compresso Sorbitol 5.835 mg Talcum
Source Data was imported : 05.04.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
